BeOne Medicines and Revolution Medicines Enter Collaboration for Clinical Development and Regional Commercialization
BeOne Medicines and Revolution Medicines Announce Broad Oncology Collaboration to Advance RAS-Targeted Therapies BeOne Medicines Ltd. and Revolution Medicines, Inc. have announced a multi-part strategic collaboration aimed at expanding treatment…
Innate Pharma and Sobi Enter Strategic Partnership to Advance Lacutamab in T-Cell Lymphoma
Innate Pharma and Sobi Partner to Advance Lacutamab into Phase 3 Development for Cutaneous T-Cell Lymphoma Innate Pharma SA and Swedish Orphan Biovitrum AB (publ), widely known as Sobi®, have…
Cerepeut’s Lead Compound Reveals Novel Mitochondrial Mechanism Driving Neurodegeneration
Cerepeut Study in Neuron Identifies Mitochondrial Mechanism Driving Tau-Related Neurodegeneration and Highlights CP-235 as Potential Therapy Cerepeut, Inc., a biotechnology company focused on developing mitochondrial therapeutics for neurodegenerative diseases, has…
Battelle Demonstrates Advanced Biotechnology Capabilities During NSCEB Ohio Visit
Battelle Hosts National Security Commission on Emerging Biotechnology to Highlight Ohio’s Growing Biotechnology Capabilities Battelle recently welcomed members of the National Security Commission on Emerging Biotechnology (NSCEB) to its Columbus,…
AHF Supports New Senate Bill to Protect the 340B Drug Pricing Program
AIDS Healthcare Foundation Supports Bipartisan SUSTAIN 340B Act to Strengthen and Protect Federal Drug Discount Program AIDS Healthcare Foundation (AHF) has welcomed the introduction of draft bipartisan legislation in the…
Multi-Center Study Finds equicenta® CTM Outperforms Standard Care in Returning Performance Horses to Work
Multicenter Study Demonstrates Superior Outcomes with equicenta® CTM for Returning Performance Horses to Work Equine Performance Labs (EPL), the company behind equicenta® CTM, has announced the publication of new peer-reviewed…
eClinicalWorks and healow Help Endocrinology Practice Enhance Chronic Care and Reduce Missed Appointments
Diabetes and Metabolism Specialists Improves Patient Engagement and Chronic Care Management with eClinicalWorks Digital Solutions eClinicalWorks®, a leading ambulatory cloud electronic health record (EHR) provider, announced that Diabetes and Metabolism…
City of Hope Study Shows Survivor Outreach Can Significantly Reduce Skin Cancer Risk After Bone Marrow Transplant
City of Hope Study Shows Education Program Can Dramatically Improve Skin Cancer Screening Among Hematopoietic Cell Transplant Survivors Experts at City of Hope®, one of the nation’s leading cancer research…
LabPMM® Launches Global KMT2A MRD Testing Service to Advance Menin Inhibitor Development and Leukemia Care
LabPMM Launches Global KMT2A Measurable Residual Disease Testing Service to Advance Precision Monitoring in Acute Leukemia LabPMM®, a subsidiary of Invivoscribe®, has announced the worldwide launch of its new KMT2A…
Clinilabs Announces New Medical Leadership Appointments
Clinilabs Strengthens Executive Leadership with the Appointments of Dr. Bob Dagher as Chief Medical Officer and Dr. Waqar Ahmed Siddiqui as Principal Investigator Clinilabs LLC, a global full-service contract research…
Helen Branswell Receives FNIH Kovler Prize for Excellence in Life Science Journalism
Helen Branswell Named Recipient of the 2026 Kovler Prize for Trust in Life Science Journalism The Foundation for the National Institutes of Health (FNIH) has announced that renowned infectious disease…
Enveric Biosciences Reports Preclinical Data Confirming Non-Hallucinogenic Profile of EB-003
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Neuroplastogenic Candidate EB-003 Enveric Biosciences, a clinical-stage biotechnology company focused on developing next-generation neuroplastogenic small-molecule therapies for psychiatric…